Enabled Therapeutics

Enabled Therapeutics is at the forefront of biotechnology research, spearheading innovative solutions for CNS drug development. With a groundbreaking pathology-gated therapeutic activation technology for small molecules, Enabled Therapeutics is uniquely positioned to overcome long-standing barriers in treating brain diseases. Enabled Therapeutics’ pioneering approach ensures precision, effectiveness, and a future of possibilities in neurology.

Enabled Therapeutics’ revolutionary small-molecule technology remains inactive in healthy brain regions, activating only where pathology exists. This targeted approach allows for the treatment of Alzheimer’s, epilepsy, ALS, glioblastoma, and other devastating conditions with unprecedented precision. Supported by compelling data and guided by an experienced team, Enabled Therapeutics is poised to enter clinical trials soon, marking a significant step forward in addressing previously undruggable CNS targets.

Enabled Therapeutics, located in San Francisco, US, is committed to transforming the landscape of neurology. By focusing on precision and innovation, Enabled Therapeutics is paving the way for groundbreaking advancements in CNS therapeutics. The company’s dedication to pushing the boundaries of medical science promises a future where debilitating brain diseases can be effectively treated. Enabled Therapeutics invites you to explore the possibilities and welcomes collaboration to further its mission of revolutionizing neurological treatments.

To the manager of Enabled Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform to further amplify your reach and impact.